Efficacy and Safety of Ceftazidime-Avibactam for the Treatment of Carbapenem-Resistant Enterobacterales Bloodstream Infection: a Systematic Review and Meta-Analysis

Several clinicians use ceftazidime-avibactam (CAZ-AVI) to treat bloodstream infections (BSIs) due to carbapenem-resistant Enterobacterales (CRE), although no conclusive data support this practice. We aimed to assess the efficacy and safety of CAZ-AVI in the treatment of CRE bacteremia. PubMed, Embas...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yan, Huang, Hui-Bin, Peng, Jin-Min, Weng, Li, Du, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9045088/
https://www.ncbi.nlm.nih.gov/pubmed/35377233
http://dx.doi.org/10.1128/spectrum.02603-21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9045088/
https://www.ncbi.nlm.nih.gov/pubmed/35377233
http://dx.doi.org/10.1128/spectrum.02603-21

Ejemplares similares